Future of coagulation factor replacement therapy-Reference-Cited by-同舟云学术

Future of coagulation factor replacement therapy

Published:2013-06 Issue: Volume:11 Page:84-98
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Peyvandi F.¹²,Garagiola I.¹²,Seregni S.¹²

Affiliation:

1. Angelo Bianchi Bonomi Haemophilia and Thrombosis Center; Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico

2. Department of Phatophysiology and Transplantation; Università degli Studi di Milano; Luigi Villa Foundation; Milan Italy

Funder

Novo Nordisk

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.12270/fullpdf

Reference87 articles.

1. The hemophilias-from royal genes to gene therapy;Mannucci;N Engl J Med,2001

2. Thirty years of hemophilia treatment in the Netherlands, 1972-2001;Plug;Blood,2004

3. Design and operation of a recombinant mammalian cell manufacturing process for rFVIII;Adamson;Ann Hematol,1994

4. Molecular cloning of a cDNA encoding human antihaemophilic factor;Toole;Nature,1984

5. Expression, purification, and characterization of recombinant gamma-carboxylated factor IX synthesized in Chinese hamster ovary cells;Kaufman;J Biol Chem,1986

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factor IX stimulants in preclinical and early phase trials for hemophilia B treatment;Expert Opinion on Investigational Drugs;2024-08-11

2. Clinical data on treatment regimen and use of medication among patients with hemophilia B in Korea;Blood Research;2024-08-08

3. Real-world data on treatment regimen and medical use among patients in hemophilia B in Korea;2024-02-15

4. Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A/B): a multicentre, open-label, randomised, phase 3 trial;The Lancet Haematology;2023-05

5. Efficacy of emicizumab is maintained throughout dosing intervals for bleed prophylaxis;Research and Practice in Thrombosis and Haemostasis;2023-02